✦ LIBER ✦

A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma

✍ Scribed by Ingmar Bruns; Ulrich Steidl; Ralf Kronenwett; Roland Fenk; Thorsten Graef; Ulrich-Peter Rohr; Frank Neumann; Johannes Fischer; Christof Scheid; Kai Hübel; Rainer Haas; Guido Kobbe

Book ID: 109143092
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 77 KB
Volume: 46
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2006.00699.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cyclophosphamide with or witho

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

✍ Gojo, I; Guo, C; Sarkodee-Adoo, C; Meisenberg, B; Fassas, A; Rapoport, A P; Cott 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Viable CD34+/CD133+ blood progenitor cel

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Efficacy of single-dose pegfilgrastim af

Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma

✍ Frank Kroschinsky; Kristina Hölig; Uwe Platzbecker; Kirsten Poppe-Thiede; Rainer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Cost-effectiveness of CD34+ dose in peri

Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin’s lymphoma patients: a single centre study

✍ Limat, S; Woronoff-Lemsi, M C; Deconinck, E; Racadot, E; Jacquet, M; Herve, P; C 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Prospective randomized comparative obser

Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin’s lymphoma

✍ Shin Kim; Hyo-Jung Kim; Jung Sun Park; Jungsin Lee; Hyun-Sook Chi; Chan Jeong Pa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 98 KB

Ifosamide, epirubicin and granulocyte co

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschütz; A. Franke; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC